002737SZSE

Announcement of the Resolutions of the 17th Meeting of the 5th Board of Directors

Sunflower Pharmaceutical Group Co., Ltd.·March 2, 2026·3 pages

✨ AI Summary

The 17th meeting of the 5th Board of Directors of Sunflower Pharmaceutical Group Co., Ltd. was held on March 2, 2026. The board reviewed and approved proposals related to related party transactions for the 2026 Annual General Meeting. Key figures include estimated transaction amounts totaling 15,615.00 (10,000 RMB), primarily for product sales and consulting services with Sunflower Group Co., Ltd. and Hainan Sunflower Technology Co., Ltd. All proposals were approved unanimously or with a majority vote.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

1. Board Meeting Invitation

Sunflower Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") held the 17th meeting of the 5th Board of Directors on March 2, 2026, at 9:00 AM via telecommunication. The meeting was convened in accordance with the relevant provisions of the Company Law and the Articles of Association. A total of 9 directors attended the meeting.

2. Board Meeting Review

1. Review of the Proposal on Related Party Transactions for the 2026 Annual General Meeting

The proposal was approved with 5 votes in favor, 0 votes against, and 0 abstentions.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.